Erratum: Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B (Gynecologic Oncology (2005) 98 (467-483) DOI: 10.1016/j.ygyno.2005.05.003);Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B

Gynecologic Oncology

Volumn 98, Issue 3, 2005, Pages 467-483

  Mathur, Subbi P ^a   Mathur, Rajesh S ^a   Gray, Elizabeth A ^a   Lane, Derrick ^a   Underwood, Paul G ^a   Kohler, Matthew ^a   Creasman, William T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cervical cancer; Early diagnosis

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN B; VASCULOTROPIN C;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LINEAR REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PAPANICOLAOU TEST; PRIORITY JOURNAL; SERUM; SQUAMOUS CELL; STUDENT T TEST; TUMOR BIOPSY; UPREGULATION; UTERINE CERVIX CANCER;

EID: 23844460517     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.12.018     Document Type: Erratum

References (35)

1. Mathur SP, Landen CP, Datta SM, Hoffmann MC, Mathur RS, Young RC. Insulin-like growth factor II levels in gynecological cancers. J. Am. Rep. Immunol. 49(2):113-9, 20.
2. S.P. Mathur, R.S. Mathur, and R.C. Young Cervical epidermal growth factor receptor [EGF-R] and insulin-like growth factor II [IGF-II] levels in women with cervical cancer and cervical intraepithelial neoplasia [CIN] Am. J. Reprod. Immunol. 44 2000 222 230
3. S.P. Mathur, R.S. Mathur, P.B. Underwood, M.F. Kohler, and W.T. Creasman Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer Gynecol. Oncol. 91 2003 486 493
4. S.P. Mathur, R.S. Mathur, W.T. Creasman, P.G. Underwood, and M. Kohler Early diagnosis of cervical cancer: beyond human papilloma virus (HPV) testing Dis. Markers 21 2005 1 9
5. A.J. Karaviannakis, K.N. Syrigos, A. Polychronidis, A. Zbar, G. Kouraklis, and C. Simopoulos Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival and rumor surgery Ann. Surg. 236 1 2002 37 42
6. G. Holzer, A. Obermair, M. Koschat, O. Preyer, R. Kotz, and K. Trieb Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors Med. Pediatr. Oncol. 36 6 2001 601 604
7. M. Kitamura, M. Toi, K. Arai, Y. Iwasaki, H. Suzuki, and K. Matsuo Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients Oncol. Rep. 5 6 1998 1419 1424
8. P.O. Van Trappen, K. Ryan, C. Lecoeur, V.G. Gyselman, B.D. Young, and D.G. Lowe A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer Br. J. Cancer 87 2002 537 544
9. B. Bachtiary, E. Selzer, T.H. Knocke, R. Potter, and A. Obermair Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival Cancer Lett. 179 2002 197 203
10. P.O. Van Trappen, D. Steele, D.G. Lowe, S. Baithun, N. Beasley, and W. Thiele Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different grades of cervical carcinogenesis J. Pathol. 201 4 2003 (Dec.) 544 554
11. J. Fujimoto, H. Toyoki, E. Sato, H. Sakaguchi, and T. Tamaya Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers Br. J. Cancer 91 3 2004 (Aug. 2) 466 469
12. C. Scavelli, E. Weber, M. Agliano, T. Cirulli, B. Nico, and A. Vacca Lymphatics at the crossroads of angiogenesis and lymphangiogenesis J. Anat. 204 6 2004 (Jun.) 433 449
13. S.F. Schoppmann, P. Birner, J. Stockl, R. Kalt, R. Ullrich, and C. Caucig Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis Am. J. Pathol. 161 3 2002 (Sep.) 947 956
14. M.S. Pepper, J.C. Tille, R. Nisato, and M. Skobe Lymphangiogenesis and tumor metastasis Cell Tissue Res. 314 1 2003 (Oct.) 167 177
15. R.E. Nisato, J.C. Tille, and M.S. Pepper Lymphangiogenesis and tumor metastasis Thromb. Haemostasis 90 4 2003 (Oct.) 591 597
16. Y. Kimura, M. Watanabe, T. Ohga, H. Saeki, Y. Kakeji, and H. Baba Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma Oncol. Rep. 10 6 2003 (Nov.-Dec.) 1747 1751
17. X.E. Liu, X.D. Sun, and J.M. Wu Expression and significance of VEGF-C and FLT-4 in gastric cancer World J. Gastroenterol. 10 3 2004 (Feb. 1) 352 355
18. C.J. Hung, D.G. Ginzinger, R. Zarnegar, H. Kanauchi, M.G. Wong, and E. Kebebew Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors J. Clin. Endocrinol. Metab. 88 8 2003 (Aug.) 3694 3699
19. R.F. Tang, J. Itakura, T. Aikawa, K. Matsuda, H. Fujii, and M. Korc Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer Pancreas 22 3 2001 (Apr.) 285 292
20. C.M. Holland, K. Day, A. Evans, and S.K. Smith Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer Br. J. Cancer 89 5 2003 (Sep. 1) 891 898
21. J.M. Arencibia, A.V. Schally, M. Krupa, A.M. Bajo, A. Nagy, and K. Szepeshazi Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness Int. J. Oncol. 19 3 2001 (Sep.) 571 577
22. S.P. Gunningham, M.J. Currie, C. Han, B.A. Robinson, P.A. Scott, and A.L. Harris The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers Clin. Cancer Res. 6 11 2000 (Nov.) 4278 4286
23. M.E. Stearns, M. Wang, Y. Hu, G. Kim, and F.U. Garcia Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF-D and flt-4t (Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis Lab. Invest. 84 6 2004 (Jun.) 785 795
24. M. Tamura, M. Oda, Y. Tsujezuka, I. Matsumoto, K. Kawakami, and Y. Ohta Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer Chest 126 2004 342 346
25. X. Li, and U. Erikkson Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D Int. J. Biochem. Cell Biol. 33 4 2001 421 426
26. H.Y. Shin, M.L. Smith, K.J. Toy, P.M. Williams, R. Bizios, and M.E. Gerritsen VEGF-C mediates cyclic pressure-induced endothelial cell proliferation Physiol. Genomics 11 3 2002 245 251
27. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YN, Smith SK, Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J. Clin. Endocrinol. Metab. 86(4):1823-34.
28. F.J. Hoar, S. Chaudhri, M.S. Wadley, and P.S. Stonalake Co-expression of vascular endothelial growth factor C [VEGF-C] and C-erbB2 in human breast carcinoma Eur. J. Cancer 39 12 2003 1698 1703
29. M. Kawakami, T. Furuhata, Y. Kimura, K. Yamaguchi, F. Hata, and K. Sasaki Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer Surgery 133 3 2003 300 308
30. M. Arinaga, T. Noguchi, S. Takeno, M. Chujo, T. Miura, and Y. Uchida Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma Cancer 97 2 2003 457 464
31. S.E. Duff, C. Li, A. Renehan, S.T. O'Dwyer, and S. Kumar Immunodetection and molecular forms of plasma vascular endothelial growth factor-C Int. J. Oncol. 22 2 2003 339 343
32. R.S. Mathur, and S. Mathur Vascular endothelial growth factor (VEGF) upregulates epidermal growth factor receptor and downregulates IGF-BP3 in vitro in cervical cancer: these effects are mediated through HPV-E6 in HPV positive cervical cancers Gynecol. Oncol. 97 2005 206 212
33. S.P. Mathur, and R.S. Mathur In vitro down regulation of growth factors by insulin-like growth factor binding protein 3 in cervical cancer Gynecol. Oncol. 91 2003 410 415
34. R.S. Galen, and S.R. Gambino Beyond Normality: The Predictive Value and Efficiency of Medical Diagnoses 1975 Wiley New York
35. D. Lane, E.A. Gray, R.S. Mathur, and S.P. Mathur Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines Am. J. Reprod. Immunol. 53 2005 153 158